Aqr Capital Management LLC Amgen Inc Transaction History

Aqr Capital Management LLC

$58.2 Billion
Q1 2024

A detailed history of Aqr Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 257,572 shares of AMGN stock, worth $80.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

257,572

Previous 941,897 72.65%

Holding current value

$80.5 Million

Previous $271 Million 73.01%

% of portfolio

0.13%

Previous 0.51%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $184 Million - $222 Million	-684,325 Reduced 72.65%	257,572 $73.2 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $36.9 Million - $41.6 Million	144,153 Added 18.07%	941,897 $271 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $19.2 Million - $23.8 Million	87,760 Added 12.36%	797,744 $214 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $13.7 Million - $16.1 Million	63,736 Added 9.86%	709,984 $158 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $8.97 Million - $10.9 Million	39,731 Added 6.55%	646,248 $156 Million

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $4.35 Million - $5.53 Million	-18,991 Reduced 3.04%	606,517 $159 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $13 Million - $14.7 Million	58,049 Added 10.23%	625,508 $141 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $38.1 Million - $42.4 Million	-165,312 Reduced 22.56%	567,459 $137 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $33.8 Million - $37.4 Million	-154,224 Reduced 17.39%	732,771 $177 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $59.1 Million - $67.7 Million	-297,260 Reduced 25.1%	886,995 $200 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $3.85 Million - $4.51 Million	-18,128 Reduced 1.51%	1,184,255 $252 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $17 Million - $18.8 Million	72,616 Added 6.43%	1,202,383 $291 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $15.6 Million - $18.1 Million	70,114 Added 6.62%	1,129,767 $281 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $30.1 Million - $35.8 Million	-139,105 Reduced 11.6%	1,059,653 $240 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $42.8 Million - $47.6 Million	-182,304 Reduced 13.2%	1,198,758 $300 Million
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $72.7 Million - $89.2 Million	-367,555 Reduced 21.02%	1,381,062 $321 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $67.2 Million - $89.1 Million	368,603 Added 26.71%	1,748,617 $351 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $34.5 Million - $44.4 Million	182,509 Added 15.24%	1,380,014 $331 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $86.5 Million - $104 Million	-496,897 Reduced 29.33%	1,197,505 $232 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $178 Million - $209 Million	-1,068,591 Reduced 38.68%	1,694,402 $312 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $58.3 Million - $65.7 Million	-322,075 Reduced 10.44%	2,762,993 $525 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $31.7 Million - $37 Million	177,493 Added 6.1%	3,085,068 $601 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $143 Million - $162 Million	773,506 Added 36.25%	2,907,575 $603 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $127 Million - $143 Million	-764,378 Reduced 26.37%	2,134,069 $394 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $126 Million - $147 Million	-743,483 Reduced 20.41%	2,898,447 $494 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $121 Million - $135 Million	714,906 Added 24.42%	3,641,930 $633 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $490 Million - $559 Million	2,927,024	2,927,024 $546 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Amgen Inc Transaction History